Pathological crystallization of human immunoglobulins

Condensation of Igs has been observed in pharmaceutical formulations and in vivo in cases of cryoglobulinemia. We report a study of monoclonal IgG cryoglobulins overexpressed by two patients with multiple myeloma. These cryoglobulins form crystals, and we measured their solubility lines. Depending on the supersaturation, we observed a variety of condensate morphologies consistent with those reported in clinical investigations. Remarkably, the crystallization can occur at quite low concentrations. This suggests that, even within the regular immune response to infections, cryoprecipitation of Ig can be possible.

[1]  J. Stone,et al.  The cryoglobulinaemias , 2012, The Lancet.

[2]  Bruce D Mason,et al.  Opalescence of an IgG2 monoclonal antibody solution as it relates to liquid-liquid phase separation. , 2011, Journal of pharmaceutical sciences.

[3]  G. Benedek,et al.  Phase separation in solutions of monoclonal antibodies and the effect of human serum albumin , 2011, Proceedings of the National Academy of Sciences.

[4]  T. Osslund,et al.  Crystallization and liquid‐liquid phase separation of monoclonal antibodies and fc‐fusion proteins: Screening results , 2011, Biotechnology progress.

[5]  Bruce D Mason,et al.  Liquid-liquid phase separation of a monoclonal antibody and nonmonotonic influence of Hofmeister anions. , 2010, Biophysical journal.

[6]  K. Anderson,et al.  Monoclonal gammopathy of undetermined significance: a consensus statement , 2010, British journal of haematology.

[7]  Hollis Lau,et al.  The use of native cation‐exchange chromatography to study aggregation and phase separation of monoclonal antibodies , 2010, Protein science : a publication of the Protein Society.

[8]  Kiichi Fukui,et al.  Phase Separation of an IgG1 Antibody Solution under a Low Ionic Strength Condition , 2010, Pharmaceutical Research.

[9]  D. Esseltine,et al.  Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Lonial,et al.  Review of peripheral neuropathy in plasma cell disorders , 2008, Hematological oncology.

[11]  Neer Asherie,et al.  Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human gamma D-crystallin. , 2005, Biochemistry.

[12]  J. King,et al.  Enhanced crystallization of the Cys18 to Ser mutant of bovine gammaB crystallin. , 2001, Journal of molecular biology.

[13]  J. King,et al.  Crystal cataracts: Human genetic cataract caused by protein crystallization , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Benedek,et al.  Aeolotopic interactions of globular proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Taussig,et al.  Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody—antigen interaction , 1997, Nature Structural Biology.

[16]  J. Maniloff,et al.  Characterization of monoclonal IgG cryoglobulins: fine-structural and morphological analysis. , 1987, Blood.

[17]  M. Klein,et al.  Nucleation-controlled polymerization of human monoclonal immunoglobulin G cryoglobulins. , 1982, The Journal of biological chemistry.

[18]  G. Litman,et al.  Thermodynamic basis for the abnormal solubility of monoclonal cryoimmunoglobulins. , 1980, The Journal of biological chemistry.

[19]  J. L. Lippert,et al.  Study of the kinetic and structural properties of a monoclonal immunoglobulin G cryoglobulin. , 1980, The Journal of biological chemistry.

[20]  S. Salmon,et al.  A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.

[21]  F. Putnam.  Abnormal human serum globulins. , 1955, Science.

[22]  Abraham M Lenhoff,et al.  Interactions and phase behavior of a monoclonal antibody , 2011, Biotechnology progress.